Page 71 - MemoriaESP-Eng

www.ciberesp.es

• t M, V x, c-p D, b M, g p, A-p A. Pilot study to
Most relevant uneuAllesArnicerontArberAoDoyVecillAAlAu
introduce a notification card for partner notification of sexually transmitted infections
scientific in Catalonia, Spain, June 2010 to June 2011.Euro Surveill. 2013 Jul 4;18(27).

articles
• MAnzArDo c, esteVe A, ortegA n, poDzAMczer D, MurillAs J, segurA F et Al.. Optimal timing
for initiation of highly active antiretroviral therapy in treatment-naïve human immu-

nodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the
experience of the PISCIS Cohort.Clin Microbiol Infect. 2013 Jul;19(7):646-53.

• M Mt, i sM, c D, J Ac, W F, c M .. Cohort profile:
AyngleostAgliolAusticeDe olFAVAssiniet Al
Antiretroviral Therapy Cohort Collaboration (ART-CC).Int J Epidemiol. 2013 Apr 18;.

• MocroFt A, lunDgren JD, sAbin Ml, MonForte AD, brocKMeyer n, cAsAbonA J et Al.. Risk fac-
tors and outcomes for late presentation for HIV-positive persons in Europe: results

from the Collaboration of Observational HIV Epidemiological Research Europe Study
(COHERE).PLoS Med. 2013;10(9):e1001510.

• s V, b e, J-l e, c s, A M, s e .. Rele-
AluDesAscuñAnAorDAnAlucHAsAnoVAsrDèVololeret Al
vance of baseline viral genetic heterogeneity and host factors for treatment outcome

prediction in hepatitis C virus 1b-infected patients.PLoS One. 2013;8(8):e72600.

CEEISCAT has led the European project HIV COBATEST which included 10 Asso-
Highlights
ciated Partners from 8 European countries and 23 Collaborating Partners. One
of its main results has been a network of 59 community screening centers in 16

countries in which to operation research. In December, the group signed the Grant
Agreement as group leader of a new DG SANCO, Euro HIV EDAT (2014-2017),

with a budget of EUR 1.3 million, 13 partners from 8 countries and 14 collabora-

ting countries.

CEEISCAT has consolidated the PISCIS Cohort of HIV positive patients, increasing
its coverage in Catalonia (12 hospitals in Catalonia and 2 from the Balearic Is-

lands). Nowadays, the cohort is monitoring 14,000 patients.

CEEISCAT has established the Working Group for early diagnosis of HIV in Primary

HealthCareinSpainincollaborationwithsemFYC, CAMFiC,IDIAPGolandGurina
and Programme for AIDS Prevention and Care Department of Health .

During 2013 the report SIVES 2012 has been published, it included information

on HIV and other STIs prevalence, incidence, related risk behavior, diagnostic
activity and therapeutic effectiveness. It also included a leaflet with the indicators

defined by ECDC available and applicable in Catalonia in 2012 to keep track of the

Dublin Declaration and the “ Treatment Cascade “ to estimate and monitor access
to diagnosis and treatment of HIV.

CEEISCAT collaborated on the Technical Report EMIS 2010, which contained the

results of the analysis of the survey implemented on the Internet aimed at men
who have sex with men in 38 countries of the European Region of WHO. The aim 13
20
of the survey was to investigate aspects of sexuality , sexual behaviors and STIs T
OR
in this group.
P
RE
L
A
NU
N
A
P /
S
RE
E
IB
C

71